COMMUNITY CLINICAL ONCOLOGY PROGRAM

夏威夷少数民族社区临床肿瘤学的目标 计划(MBCCOP)是为了降低癌症的发病率、发病率和死亡率 在夏威夷，由： A.为扩大夏威夷的临床研究提供支持， 以非高加索癌症患者为主的多民族人口； B.带来最先进的治疗和癌症的优势 对少数民族个体自身的防控研究 社区； C.增加初级保健提供者和其他人员的参与 癌症预防和控制研究方面的专家； D.加强目前存在的业务基础，以扩大 这一人群的癌症预防和控制研究； E.审查与审判有关的具体问题，如征聘和 坚持作为夏威夷民族文化特征的函数 人口。 夏威夷癌症研究中心将作为行政管理机构 MBCCOP总部用于指导招聘、应计和数据 NCI批准的癌症治疗和控制临床试验的管理。 该中心及其工作人员在以下方面拥有丰富的经验 开发和开展临床试验研究。西南肿瘤学 小组、M.D.安德森和儿科肿瘤学小组是夏威夷 MBCCOP研究基地。参与的医生包括所有 瓦胡岛上的肿瘤学家以及来自其他国家的专业人士 医学和非医学专业。所有主要的瓦胡岛医院都将为 作为组成机构。MBCCOP将允许夏威夷人民，80% 其中包括亚洲和太平洋岛民，以受益于国家- 最先进的癌症治疗和控制干预措施。

The objective of the Hawaii Minority-Based Community Clinical Oncology Program (MBCCOP) is to reduce cancer incidence, morbidity, and mortality in Hawaii by: a. providing support to expand clinical research in the state of Hawaii, a multiethnic population with a majority of non-Caucasian cancer patients; b. bringing the advantages of state-of-the-art treatment and cancer prevention and control research to minority individuals in their own communities; c. increasing the involvement of primary health care providers and other specialists in cancer prevention and control studies; d. strengthening the operational base that currently exists to extend cancer prevention and control research in this population; e. examining specific trials-related issues such as recruitment and adherence as a function of ethnocultural characteristics of Hawaii's population. The Cancer Research Center of Hawaii will serve as the administrative headquarters for the MBCCOP to direct recruitment, accrual, and data management for NCI-approved cancer treatment and control clinical trials. The Center and its personnel have extensive previous experience in developing and conducting clinical trials research. The Southwest Oncology Group, M.D. Anderson, and the Pediatric Oncology Group are the Hawaii MBCCOP research bases. The participating physicians include all oncologists on the island of Oahu, as well as professionals from other medical and non-medical specialties. All major Oahu hospitals will serve as component institutions. The MBCCOP will allow the people of Hawaii, 80% of whom are Asian and Pacific Islanders, to benefit from access to state- of-the-art cancer treatment and control interventions.